INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2021

NAD+ levels decline with age across several organisms, and restoring levels is being explored to address age-related metabolic and cognitive decline.

This review examines how ageing impacts NAD+ metabolism and describes strategies to counter its age-dependent decline. NAD+ serves as a vital coenzyme and signalling molecule consumed by enzymes like PARPs, SARM1, sirtuins, and CD38. Tissue NAD+ levels decrease during ageing due to an imbalance between synthesis and consumption, and this decline has been linked to metabolic diseases and cognitive decline. Therapeutic augmentation of NAD+ levels may halt or reverse the progression of certain age-related conditions.

Study type
Narrative review
Who was studied
Humans and other organisms (ageing context)
What was measured
NAD+ biosynthesis, consumption, and age-related diseases

THE PAPER

The balance between NAD+ biosynthesis and consumption in ageing.

Strømland Ø, Diab J, Ferrario E, Sverkeli LJ, Ziegler M. Mech Ageing Dev, 2021.

PubMed 34509469 ↗DOI 10.1016/j.mad.2021.111569 ↗

Nutrients & adequacyBrain & moodHealthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.